The Rundown cover image

Eli Lilly Acquires Bowel Disease Drug Developer for $3.2B, Boeing Pleads Guilty to Felony Charge

The Rundown

00:00

Boeing's Challenges, Eli Lilly's Acquisition, and KOSS Stock Movement

This chapter covers Boeing's challenges due to the halt in 737 MAX orders, Eli Lilly's acquisition of drug developer Morphic Holding, and the stock movement of KOSS as a meme stock speculated by Roaring Kitty.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app